Study guide

5.7 Lymphoma, Sarcoma, Skin, Leukemia & Oncologic Emergencies

ARRT Radiation Therapy Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Patient Care & Education

1.1 Patient Assessment, History, and Vital Signs 1.2 Psychosocial Support & Coping Mechanisms 1.3 Patient & Family Education on Radiation Therapy 1.4 Radiation Side Effect Management: Skin & Mucosal Reactions 1.5 Radiation Side Effect Management: Systemic & Organ-Specific Side Effects 1.6 Nutritional Support & Management of Dysphagia/Odynophagia 1.7 Medical Emergencies in Radiation Oncology 1.8 Patient Rights, Informed Consent, and Advanced Directives 1.9 Ethical, Legal, and HIPAA Considerations for Radiation Therapists 1.10 Infection Control & Sterile Technique in Radiation Therapy 1.11 Transfer & Positioning Safety for Oncology Patients 1.12 Pharmacology & Contrast Media in Radiation Therapy 1.13 Cancer Epidemiology, Screening & Diagnostic Evaluation

2 Chapter 2: Radiation Physics, Radiobiology & Protection

2.1 Structure of Matter, Electromagnetic & Particulate Radiation 2.2 Radiation Production in Linear Accelerators & X-Ray Tubes 2.3 Photon & Electron Beam Interactions with Matter 2.4 Radiation Measurement Quantities, Units & Dosimeters 2.5 Radiation Protection Principles: ALARA, Time, Distance & Shielding 2.6 NCRP Dose Limits for Occupational & Public Exposure 2.7 Vault Design, Primary & Secondary Protective Barriers 2.8 Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's) 2.9 Linear Energy Transfer (LET) & Relative Biological Effectiveness (RBE) 2.10 Acute & Late Radiation Effects on Normal Tissues 2.11 Radiation Safety Rules, Emergency Procedures & Sealed Source Safety 2.12 MRI Magnetic Field Screening for Radiation Therapy Patients

3 Chapter 5: Treatment Sites, Tumors & Classification

5.1 Brain, Spinal Cord Tumors & Metastatic Patterns 5.2 Head & Neck Sites: Anatomy, Lymphatics & Patterns of Spread 5.3 Breast Cancer: Anatomy, Lymphatic Drainage & Radiation Considerations 5.4 Lung & Thoracic Tumors: Anatomy, Spread & Critical Structures 5.5 Abdomen, Pelvis, GI & GU Sites: Anatomy & Metastatic Patterns 5.6 Reproductive System Tumors: Prostate, Cervix & Related Sites 5.7 Lymphoma, Sarcoma, Skin, Leukemia & Oncologic Emergencies 5.8 Tumor Classification: Histopathology, Grade & Staging Systems

4 Chapter 3: Treatment Planning & Dosimetry

3.1 CT Simulation, Patient Positioning & Target Localization 3.2 Immobilization Devices & Radiopaque Marking Protocols 3.3 ICRU Target Volume Definitions (GTV, CTV, PTV, PRV, OAR) 3.4 Beam Modifiers: Wedges, Compensators, Bolus & MLC Systems 3.5 Depth Dose Characteristics: PDD, TMR, TPR & TAR Relationships 3.6 Monitor Unit (MU) Calculations & Clinical Dosimetry Formulas 3.7 3D Conformal Radiation Therapy (3D-CRT) Beam Arrangements 3.8 IMRT, VMAT & Inverse Planning Optimization Concepts 3.9 SRS, SBRT & Stereotactic Radiosurgery Techniques 3.10 Brachytherapy Principles, HDR, LDR & Isotopes 3.11 Dose Volume Histograms (DVH) & QUANTEC Tissue Tolerances

5 Chapter 4: Treatment Delivery, Image Guidance & QA

4.1 Pre-Treatment Chart Check & Plan Verification Protocols 4.2 Daily Patient Positioning, Setup Tolerances & Alignment Verification 4.3 Image-Guided Radiation Therapy (IGRT): Portal Imaging & CBCT Verification 4.4 Linear Accelerator Safety Systems, Interlocks & Gantry Controls 4.5 Special Techniques: TBI, TSI, SGRT & Gated Radiotherapy 4.6 Daily Linac Quality Assurance per AAPM TG-142 Specifications 4.7 Monthly & Annual Linac QA Requirements & Dosimetric Calibration 4.8 Patient-Specific IMRT QA & In-Vivo Dosimetry Verification 4.9 Machine Malfunctions, Override Protocols & Emergency Off Procedures 4.10 Record and Verify (R&V) Systems, EHR Integration & Treatment Documentation

5.7 Lymphoma, Sarcoma, Skin, Leukemia & Oncologic Emergencies

Key Takeaways Explain This Topic AI

Hodgkin lymphoma spreads contiguously and is highly radiosensitive; treatment has shifted toward smaller, PET-defined involved-site radiation volumes to reduce late toxicity.

Soft tissue sarcoma fields follow the longitudinal muscle compartment because sarcomas spread along fascial planes, not uniformly in all directions.

Total skin electron beam therapy (TSEBT) treats mycosis fungoides by delivering uniform dose across the entire skin surface while sparing deep structures.

Total body irradiation is used in leukemia treatment mainly as transplant conditioning, not as primary localized therapy, because disease is diffusely distributed in the marrow.

Spinal cord compression and SVC syndrome are oncologic emergencies requiring immediate recognition and reporting, since delayed treatment can cause permanent neurologic damage.

Last updated: July 2026

Lymphoma: Hodgkin vs. Non-Hodgkin

Lymphomas arise from lymphoid tissue and are separated into two biologically distinct categories:

  • Feature Hodgkin lymphoma Non-Hodgkin lymphoma (NHL)
  • Hallmark cell Reed-Sternberg cell Varies by subtype (B-cell most common)
  • Spread pattern Predictable, contiguous nodal spread Often non-contiguous, can involve extranodal sites
  • Age distribution Bimodal (young adults, older adults) Increases with age
  • Radiosensitivity Highly radiosensitive Variable; often chemo-predominant

Ann Arbor staging (Stages I–IV, with A/B for absence/presence of systemic symptoms such as fever, night sweats, weight loss) classifies both Hodgkin and non-Hodgkin lymphoma by the number and location of involved nodal regions and whether extranodal/extralymphatic sites are involved.

Hodgkin lymphoma is managed with combination chemotherapy, with involved-site radiation therapy (ISRT) added for bulky disease, residual PET-positive disease, or as consolidation in early-stage favorable disease — a shift from historically larger "involved-field" or "extended-field" volumes toward smaller, PET/CT-defined target volumes to reduce late toxicity (secondary malignancy, cardiac disease) in long-surviving patients.

NHL is more often chemotherapy-predominant; radiation is used for consolidation of bulky/residual disease, for indolent subtypes as definitive low-dose therapy, or palliatively.

Soft Tissue Sarcoma

Sarcomas arise from mesenchymal tissue (muscle, fat, connective tissue, bone) rather than epithelium, distinguishing them biologically from the carcinomas that make up most solid tumors. Extremity soft tissue sarcomas are managed with limb-sparing surgical resection combined with radiation (pre- or postoperative) to maximize local control while preserving limb function — a strategy that replaced amputation as the standard of care. Radiation fields typically follow the longitudinal muscle compartment rather than a simple margin around the tumor, because sarcomas spread along fascial planes and muscle bundles rather than uniformly in all directions.

Skin Cancer

Basal cell carcinoma (BCC) is the most common skin cancer, slow-growing, and rarely metastasizes; superficial radiation therapy (SRT) or electron beam therapy is effective for lesions where surgery is undesirable (e.g., cosmetically sensitive facial sites, poor surgical candidates).

Squamous cell carcinoma (SCC) of the skin has a higher metastatic potential than BCC, particularly in immunosuppressed patients or lesions with perineural invasion; radiation is used definitively or adjuvantly, with attention to regional (parotid, cervical, or inguinal) nodal basins depending on location.

Melanoma arises from melanocytes and has the highest metastatic potential of the common skin cancers. Radiation's primary role is adjuvant (after wide local excision and/or lymph node dissection) for high-risk features (thick lesions, positive margins, extensive nodal involvement) or palliative for metastatic disease (notably brain metastases), since melanoma is not considered a routinely radiosensitive tumor in the way basal or squamous cell carcinoma can be.

Mycosis fungoides (cutaneous T-cell lymphoma) can be treated with total skin electron beam therapy (TSEBT) , a specialized technique using multiple electron fields and patient positioning (e.g., a six-dual-field rotational technique) to deliver a uniform dose to the entire skin surface while sparing deeper structures.